Publicacións en colaboración con investigadores/as de Pfizer (United States) (7)

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

2009

  1. Effect of intensive treatment with atorvastatin versus standard doses of statins on the risk of stroke. A meta-analysis from five randomized trials including 25,709 patients

    Revista de Neurologia, Vol. 48, Núm. 11, pp. 561-565

  2. Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH

    European Journal of Endocrinology, Vol. 161, Núm. 4, pp. 533-540

2007

  1. A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia

    European Neuropsychopharmacology, Vol. 17, Núm. 6-7, pp. 456-463

2006

  1. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?

    European Journal of Endocrinology, Vol. 155, Núm. 1, pp. 109-119

2005

  1. Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: A KIMS-based study

    Archives of Physical Medicine and Rehabilitation, Vol. 86, Núm. 3, pp. 463-468

2000

  1. A comparative evaluation of amlodipine and hydrochlorothiazide as monotherapy in the treatment of isolated systolic hypertension in the elderly

    Clinical Drug Investigation, Vol. 19, Núm. 5, pp. 317-326